We are live on ! Find out more
DDC

Daniel Devine & Co Portfolio holdings

AUM $125M
1-Year Est. Return 14.12%
This Fund
S&P 500
This Quarter Est. Return
+3.36%
1 Year Est. Return
+14.12%
3 Year Est. Return
+34.19%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$123M
AUM Growth
+$753K
Cap. Flow
-$3.3M
Cap. Flow %
-2.69%
Top 10 Hldgs %
70.45%
Holding
48
New
1
Increased
1
Reduced
30
Closed
1

Top Buys

Rank Stock Value
1
VVV icon
Valvoline
VVV
+$769K
2
HBI
Hanesbrands
HBI
+$6.47K

Top Sells

Rank Stock Value
1
ASH icon
Ashland
ASH
+$842K
2
GE icon
GE Aerospace
GE
+$306K
3
PFE icon
Pfizer
PFE
+$280K
4
ABBV icon
AbbVie
ABBV
+$255K
5
BX icon
Blackstone
BX
+$251K

Sector Composition

Rank Sector Weight
1 Healthcare 12.85%
2 Financials 6.92%
3 Technology 6.6%
4 Industrials 4.29%
5 Energy 3.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPY icon
1
State Street SPDR S&P 500 ETF Trust
SPY
$790B
$29.5M 24.04%
121,832
-973
-0.8% -$233K
QQQ icon
2
Invesco QQQ Trust
QQQ
$453B
$15.9M 12.98%
115,630
-250
-0.2% -$34.4K
MDY icon
3
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.6B
$14.8M 12.08%
46,615
-200
-0.4% -$63K
AAPL icon
4
Apple
AAPL
$4.54T
$7.07M 5.77%
196,252
-4,000
-2% -$148K
JNJ icon
5
Johnson & Johnson
JNJ
$618B
$4.92M 4.02%
37,207
-1,525
-4% -$195K
IBB icon
6
iShares Biotechnology ETF
IBB
$9.34B
$4.14M 3.38%
40,095
– –
EEM icon
7
iShares MSCI Emerging Markets ETF
EEM
$28.8B
$2.84M 2.32%
68,600
– –
BRK.B icon
8
Berkshire Hathaway Class B
BRK.B
$1.1T
$2.66M 2.17%
15,700
– –
CVX icon
9
Chevron
CVX
$392B
$2.32M 1.89%
22,206
-2,200
-9% -$233K
ABBV icon
10
AbbVie
ABBV
$443B
$2.22M 1.81%
30,580
-3,800
-11% -$255K
GE icon
11
GE Aerospace
GE
$374B
$2.15M 1.75%
16,589
-2,233
-12% -$306K
PFE icon
12
Pfizer
PFE
$143B
$2.03M 1.65%
63,569
-8,879
-12% -$280K
V icon
13
Visa
V
$684B
$1.98M 1.61%
21,080
-400
-2% -$37.1K
FDX icon
14
FedEx
FDX
$72.7B
$1.88M 1.54%
8,660
-200
-2% -$39.5K
NVS icon
15
Novartis
NVS
$297B
$1.81M 1.47%
24,161
-2,232
-8% -$158K
UNH icon
16
UnitedHealth
UNH
$376B
$1.69M 1.38%
9,115
-250
-3% -$43.8K
DIS icon
17
Walt Disney
DIS
$167B
$1.63M 1.33%
15,302
-250
-2% -$27.4K
ZTS icon
18
Zoetis
ZTS
$32.4B
$1.56M 1.27%
24,990
-700
-3% -$41.3K
BLK icon
19
Blackrock
BLK
$169B
$1.46M 1.19%
3,460
-100
-3% -$39.9K
GOOG icon
20
Alphabet (Google) Class C
GOOG
$4.36T
$1.46M 1.19%
31,380
-600
-2% -$27.5K
HBI
21
DELISTED
Hanesbrands
HBI
$1.41M 1.15%
60,695
+300
+0.5% +$6.47K
AZN icon
22
AstraZeneca
AZN
$263B
$1.27M 1.04%
18,700
-2,650
-12% -$173K
BX icon
23
Blackstone
BX
$102B
$1.26M 1.02%
37,670
-8,000
-18% -$251K
RDS.B
24
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$1.21M 0.99%
22,225
-2,275
-9% -$127K
SAP icon
25
SAP
SAP
$212B
$1.02M 0.83%
9,775
-425
-4% -$43.8K
1
2

Similar funds

PMLI
Penn Mutual Life Insurance Horsham, Pennsylvania $125M AUM 9.1% 1-Year Est. Return
KFA
Kabarec Financial Advisors Palatine, Illinois $131M AUM
FAM
Foundation Asset Management White Plains, New York $116M AUM 31.02% 1-Year Est. Return
MFP
Mosaic Financial Partners San Francisco, California $152M AUM 1.45% 1-Year Est. Return
MGA
MatlinPatterson Global Advisers New York $163M AUM 32.35% 1-Year Est. Return
MAI
Marble Arch Investments New York $82.3M AUM 31.35% 1-Year Est. Return
XGI
XL Group Investments Hamilton, Bermuda $169M AUM 13.59% 1-Year Est. Return
ACM
Altalis Capital Management New York $79.7M AUM 1.72% 1-Year Est. Return

Daniel Devine & Co's Q2 2017 Portfolio in Review

As of Q2 2017, Daniel Devine & Co held 48 positions worth $123M, up 0.62% from $122M the previous quarter. Its ten largest holdings account for 70% of the portfolio.

Trading was light in Q2 2017: portfolio turnover was 4.2%. Daniel Devine & Co opened 1 new position and exited 1, leaving the 48-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 13% a quarter earlier, followed by Financials and Technology.

  • Daniel Devine & Co's largest Q2 2017 buy was Valvoline: 33,186 shares worth $787K.
  • Daniel Devine & Co added most to Hanesbrands in Q2 2017, an estimated $6.47K increase.
  • Daniel Devine & Co's biggest Q2 2017 reduction was Ashland, cutting an estimated $842K.
  • Daniel Devine & Co's ten largest holdings make up 70% of its $123M portfolio in Q2 2017.
  • Daniel Devine & Co opened 1 new position and closed 1 in Q2 2017.
  • Daniel Devine & Co's portfolio value rose 0.62% quarter-over-quarter to $123M.

Based on Daniel Devine & Co's 13F filing for Q2 2017, filed 20 Jul 2017.